Annovis Bio (ANVS) announced the appointment of Mark Guerin, CPA, CMA, CFM, as Chief Financial Officer, CFO. Prior to joining Onconova, Guerin worked as an interim senior finance and accounting executive, facilitating post-acquisition integration activities of newly acquired private equity portfolio companies
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANVS:
- Annovis Bio announces publication of new article in Biomolecules on buntanetap
- Annovis Bio’s Promising Alzheimer’s Study: What Investors Need to Know
- Annovis Bio price target lowered to $10 from $12 at H.C. Wainwright
- Annovis Bio Reports Q2 2025 Progress and Financials
- Annovis Bio’s Promising Alzheimer’s Drug Trial: What Investors Need to Know